ShareValue scores for 000813.SHE: Valuation 52, Quality 28, Growth 47, Health 40.
000813.SHESZSE
Dezhan HealthCare Co Ltd
CN¥2.80
(-2.78%)
Updated
000813.SHESZSE
Dezhan HealthCare Co Ltd
Updated
Pulse
Pulse
Fundamental Rating
Value Trap Risk
If P/E met sector median
Rating
Trap Risk
P/E to median
vs Shenzhen-listed Healthcare stocks
Company Details
Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine-atorvastatin calcium tablets, warfarin sodium tablets, trimetazidine hydrochloride tablets, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathioprine tablets, hydroxyurea tablets, colchicine tablet, and oseltamivir phosphate capsules. It also involved in the provision of biopeptides, industrial hemp, and medical service business. Dezhan Healthcare Company Limited was founded in 1980 and is based in Beijing, the People's Republic of China.